| EPA0017 | Plasma derived extracellular vesicles modulate monocyte function in adults with HIV-related cognitive impairment | E-poster | HIV pathogenesis |
| EPE0791 | Pilot randomized controlled trial of a web-based decision support tool to reduce decision conflict for HIV pre-exposure prophylaxis | E-poster | Implementation science and scale up of prevention |
| OAD0502 | Pill count effectiveness in detecting nonadherence in a mature HIV program with overall high viral suppression rates in Eswatini | Oral abstract session with live Q&A | Social science theories, concepts and methods |
| EPD0651 | Physician-patient interaction quality mediates the association between HIV-related stigma and HIV-prevention behaviors among high-risk young men in Zambia | E-poster | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| EPC0361 | Pharmacy provider perceptions of pharmacy-delivered injectable prep in Kenya | E-poster | HIV prevention research |
| OAB0104 | Pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed pregnant women with HIV | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
| EPC0360 | Pharmacokinetics of on demand, single dose tenofovir rectal douche for HIV Pre-Exposure Prophylaxis in young men (ATN 163) | E-poster | HIV prevention research |
| EPC0394 | Pharmacokinetics and safety of long-acting islatravir and its novel prodrug islatravir alafenamide implants for HIV prevention | E-poster | HIV prevention research |
| TUPEB07 | Pharmacokinetic bridging with oral Lenacapavir for missed subcutaneous Q6M dosing | Poster exhibition | Antiretroviral therapies and clinical issues in adults |
| EPE0802 | Pharmacist perspectives on the implementation of pharmacist-initiated PrEP in California | E-poster | Implementation science and scale up of prevention |